Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TOP1 | P11387 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1334737 | 1.00 | FAAH (0.48) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL13320972 | 1.00 | FAAH (0.48) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL542661 | 1.00 | FAAH (0.48) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL2619763 | 1.00 | FAAH (0.48) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL542662 | 1.00 | FAAH (0.48) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL1334740 | 1.00 | FAAH (0.48) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL3295244 | 0.98 | FAAH (0.44) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL2619762 | 0.98 | FAAH (0.44) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL29955736 | 0.90 | — | — | |
| SCHEMBL157037 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119060408-A | Boron-containing graphene oxide and flexible silicon rubber-boron-containing graphene oxide neutron shielding material and preparation method thereof | 北京化工大学 | 2024-12-03 | — | — | CN | claimed |
| CN-119978575-A | Ageing-resistant emulsion and processing technology thereof | 温州佳盛乳胶制品有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119060408-A | Boron-containing graphene oxide and flexible silicon rubber-boron-containing graphene oxide neutron shielding material and preparation method thereof | 北京化工大学 | 2024-12-03 | — | — | CN | disclosed |
| US-7521581-B2 | Catalyst composition and process for producing cross-coupled compound using same | TOSOH CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| EP-1707263-B1 | Catalyst composition comprising an alkylene diamine-nickel complex and process for producing a cross-coupled compound using the same | TOSOH CORP (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-20070105826-A1 | Novel fusidic acid derivatives | LEO PHARMA A/S (DK) | 2007-05-10 | — | — | US | disclosed |
| US-20060224011-A1 | Catalyst composition and process for producing cross-coupled compound using same | TOSOH CORPORATION | 2006-10-05 | — | — | US | disclosed |
| EP-0648723-B1 | Diphenylacetylene compound, process for preparing the same and liquid crystal composition and element comprising the same | SUMITOMO CHEMICAL CO (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5658489-A | EXCELLENT ANISOTROPY OF REFRACTIVE INDEX; LOW VISCOSITY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-08-19 | — | — | US | disclosed |
| EP-0648723-A1 | Diphenylacetylene compound, process for preparing the same and liquid crystal composition and element comprising the same | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1995-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060224011-A1 | Catalyst composition and process for producing cross-coupled compound using same | C5, TST, PYM1 | FAAH 3138/4885TRPV1 3907/4885TERT 37/4885 |
| US-20070105826-A1 | Novel fusidic acid derivatives | FUS, Q6ZSR9, RPL24 | FAAH 1142/4885TRPV1 4066/4885TERT 4419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.